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The ever-increasing demand for natural products and biotechnology derived from bees and ultra-modernization of various
analytical devices has facilitated the rational and planned development of biotechnology products with a focus on human
health to treat chronic and neglected diseases. The aim of the present study was to prepare and characterize polymeric
nanoparticles loaded with Brazilian red propolis extract and evaluate the cytotoxic activity of “multiple-constituent extract in
co-delivery system” for antileishmanial therapies. The polymeric nanoparticles loaded with red propolis extract were prepared
with a combination of poly-ε-caprolactone and pluronic using nanoprecipitation method and characterized by different
analytical techniques, antioxidant and leishmanicidal assay. The red propolis nanoparticles in aqueous medium presented
particle size (200–280 nm) in nanometric scale and zeta analysis (−20 to −26 mV) revealed stability of the nanoparticles
without aggregation phenomenon during 1 month. After freeze-drying method using cryoprotectant (sodium
starch glycolate), it was possible to observe particles with smooth and spherical shape and apparent size of 200 to 400 nm.
Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and thermal analysis revealed
the encapsulation of the flavonoids from the red propolis extract into the polymeric matrix. Ultra performance
liquid chromatography coupled with diode array detector (UPLC-DAD) identified the flavonoids liquiritigenin, pinobanksin,
isoliquiritigenin, formononetin and biochanin A in ethanolic extract of propolis (EEP) and nanoparticles of red propolis extract
(NRPE). The efficiency of encapsulation was determinate, and median values (75.0 %) were calculated using UPLC-DAD.
2,2-Diphenyl-1-picryhydrazyl method showed antioxidant activity to EEP and red propolis nanoparticles. Compared to
negative control, EEP and NRPE exhibited leishmanicidal activity with an IC50 value of ≅38.0 μg/mL and 31.3 μg/mL, 47.2
μg/mL, 154.2μg/mL and 193.2 μg/mL for NRPE A1, NRPE A2, NRPE A3 and NRPE A4, respectively. Nanoparticles loaded with
red propolis extract in co-delivery system and EEP presented cytotoxic activity on Leishmania (V.) braziliensis. Red propolis
extract loaded in nanoparticles has shown to be potential candidates as intermediate products for preparation of various
pharmaceutical dosage forms containing red propolis extract in the therapy against negligible diseases such as leishmaniasis.
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Propolis is a biotechnological product with biological ac-
tivities produced by bees of the species Apis mellifera
from plant exudates which are collected and added to
organics or salivary secretions. Propolis has been widely
used in alternative and traditional medicine to treat
several diseases. The presence of secondary metabo-
lites from plants like phenolic acids, phenolic esters,
flavonoids, clerodanes, lupeones, propolones, preny-
lated benzophenones have been identified in different
propolis around the world and are responsible for the
biological activities in propolis raw material [1]. These
compounds in whole are considered a “multiple-con-
stituent extract” from a natural product and has a
multi-target purpose in biological systems [2].
Propolis have presented diverse pharmacological activ-
ities amongst them antioxidant [3], antimicrobial [4, 5],
antifungal [6, 7], antiviral [3], antiparasite [8, 9], anti-
inflammatory [3, 4], anticancer [1, 10–16] and wound
healing [17, 18], but its biological activity depends on its
particular chemical composition and some favourable
conditions such as bee species and its genetic variability,
geographic area, biodiversity of plant species around
hives, climate and sazonality and presence of water
around the hives specially in semiarid area.
Recent studies that sought to characterize Brazilian
red propolis found molecules, such as elemicin, isoe-
lemicin, methyl isoeugenol, methyl eugenol, formono-
netin, biochanin A, isoliquiritigenin, liquiritigenin,
medicarpin, homopterocarpan, quercetin and vestitol,
that allow it to be distinguished from other types of
Brazilian propolis [3, 19, 20]. The red propolis
present the unique characteristics of chemical com-
position and multiple biological activities in addition
to standardized production in the areas of mangroves
swamps of Alagoas, Brazil, respecting a environment
conservation policy of the Atlantic rainforest. Then,
the production of red propolis raw material and
hydroalcoholic extract is part of a production chain
of apiceuticals and bioproducts that promotes sustain-
able development in the region of mangroves and
lagoons being awarded the geographical indication
label with the designation of origin.
Nanoparticles have been studied since early 1990s
and used as drug nanocarriers and are be able to be
encapsulated inside nanocarriers or onto the surface
of small nanocarrier molecules, genes, biopharmaceu-
ticals and diagnostic and imaging agents [21–23]. The
nanocarriers commonly present different matrix sys-
tems (nanostructured materials) and an architecture
composed of polymers (polymeric nanoparticles), lipo-
somes (solid lipid nanoparticles, cubosomes, niosomes,
spherulites etc.) [21, 22, 24], metal nanoparticles (silicon
nanoparticles, gold nanoparticles, silver nanoparticles,magnetic nanoparticles), carbon nanotubes and quantum
dots (diagnostic image agents) [23, 25–27].
But polymeric nanoparticles and liposomes are
amongst the most accepted delivery vehicles of drugs
with clinical applications in pharmaceutical area and
approved as generally recognized as safe (GRAS).
Polymeric nanoparticles reached this status due to
biocompatibility, non-toxicity to biological systems,
biodegradability, stability during storage, controlled
release, target delivery, resulting in higher therapeutic
efficacy [21, 25, 28, 29].
Nanoparticles can be prepared by different techniques
including solvent emulsification-evaporation, high pres-
sure homogenization, high-speed stirring, ultrasonication,
microemulsion using spray-drying, nanoprecipitation and
others [29–31]. Preparation and characterization of nano-
particles loaded with isolated drugs [32], vaccines [33] or
isolated phytomedicine (kampferol, luteolin, cathechin,
quercetin) [34, 35] and propolis extract [36] are applied in
cancer therapy [37–39] and other diseases [40] including a
negligible disease such as leishmaniasis [41, 42]. However,
there are few papers describing herbal extract encapsu-
lated in nanoparticles [43–49]. Few studies describe the
use of propolis extracts with effective leishmanicidal effect
[50]. There is also a current trend in the use of conven-
tional therapy using the drug of first choice in association
[51] or drug of first choice combined with phenolic com-
pounds for treatment of various diseases resulting in en-
hancement of therapeutic efficacy or reducing the side
effect of drugs used in the therapy of diseases such as
leishmaniasis [52].
There is a great diversity in a nanoparticulate system
to transport for target tissues the drug-drug or drug
combined with phytochemicals [53, 54]. The develop-
ment of “multi-compound extract in co-delivery system”
for target tissues arises due to the high prevalence of the
number of cases of cancers [55] and the increase in
drug-resistance during leishmaniasis treatment world-
wide [56–59].
The use of bee products and propolis comes from an-
cient times to present days, and there is an increasing
interest to standardize apiceutical products for use in
the pharmaceutical and cosmetic industries. It is neces-
sary to carry out complex and diverse scientific studies
of dose, composition, formulation stability and thera-
peutic activity of this complex mixture of substances of
different phytochemical classes to ensure the efficacy,
safety, quality and productivity. Currently, pharmaceut-
ical industries have extensively explored the use of nano-
particles for “drugs in co-delivery system” in therapy
against various diseases especially for the treatment of
cancer as well as cardiovascular diseases, metabolic syn-
drome diseases and also negligible diseases. Thus, this
study aimed to explore the potential of the propolis
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pool of flavonoids and phenolic compounds which may
act in a synergistic action for treating chronic and
neglected diseases previously such as leishmaniasis.
The aim of the present study was to prepare and
characterize polymeric nanoparticles loaded with Brazilian
red propolis extract and access the antioxidant and
leishmanicidal activity of “multiple-constituent extract
in co-delivery system” present in red propolis extract
loaded in a nanoparticulate system.Methods
Propolis Sample
Red propolis raw material (150 g) was collected from
Marechal Deodoro city, state of Alagoas, Brazil. Propolis
was collected from the Ilha do Porto apiary with the fol-
lowing geographical coordinates: south latitude 9° 44.555′,
west latitude 35° 52.080′ and height of 18.1 m above sea
level. The access and transportation of Brazilian red
propolis was previously authorised by regulatory
agencies controlling Brazilian Genetic Heritage and
Biodiversity Conservation with protocol number of ac-
ceptance 010124/2012-8.Reagents
Poly-ε-caprolactone (P.M 10.000), pluronic F-108 co-
polymer (poly(ethylene glycol)-block-poly(propylene
glycol)-block-poly(ethylene glycol) (P.M. 14.000), and
2,2-diphenyl-1-picryhydrazyl (DPPH) reagents were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Analytical standards: pinobanksin, isoliquiritigenin,
formononetin and biochanin A were purcharsed from
Sigma-Aldrich (St. Louis, MO, USA), and liquiritigenin
was acquired from Extrasynthese (Lyon, France).
HPLC-grade acetonitrile was purchased from J. T.
Baker Mallinckrodt-Avantor (NJ, USA). Schneider for
insect medium was purchased from Sigma-Aldrich
(St. Louis, MO, USA). Biphasic medium Schneider’s/
Novy-McNeal-Nicolle, supplemented with 10 % of
foetal bovine serum (FBS), 50 U of penicillin/mL and
50 μg of streptomycin/mL was purchased from
Sigma-Aldrich (St. Louis, MO, USA).Table 1 Compositions of nanoparticles loaded with red propolis ext
Composition (%)
Components NRPE A1 NRPE A2
Organic phase
PCL 54.0 47.0
Red propolis extract 20.0 30.0
Aqueous phase
Pluronic 26.0 23.0Preparation of Ethanolic Extract of Propolis (EEP)
Raw propolis (250 g) was manually grounded and
placed in a flask with 600 mL of 80 % ethanol, which
was placed on an agitator (Thornton, Model T14, USA)
for 48 h. Then, the macerate (the liquid portion) was re-
moved using a pipette, and the solid portion (wax) was
discarded. The macerate was mixed with 600 mL of 80 %
ethanol in a glass flask and placed on the agitator for
24 h. Then, the resulting macerate was mixed again
with 600 mL of 80 % ethanol and left for 24 h with-
out agitation.
Next, the macerate was removed using a pipette, fil-
tered through filter paper and subjected to distillation
under reduced pressure in a rotary evaporator (Fisatom,
São Paulo, Brazil) in a water bath at temperature 40–50 °C,
pressure 650 mmHg and speed 80 rpm to remove the solv-
ent. The EEP was then placed in a glass container and left
for approximately 3 days for the residual solvent to evapor-
ate; as a result, a solid mass (162 g) with viscous appear-
ance was obtained.
Preparation of Nanoparticles Loaded with Nanoparticles
of Red Propolis Extract (NRPE)
Five nanoparticles compositions containing red propolis
extract were prepared using the polycaprolactone (PCL)-
pluronic polymeric matrix (NRPE A1, NRPE A2, NRPE
A3, NRPE A4, NRPE A5). Placebo composition (nano-
particles without red propolis extract) was also prepared.
Table 1 summarizes the components present in these
nanoparticles compositions.
The colloidal suspensions of nanoparticles were ob-
tained by the preformed polymer interfacial depos-
ition method also called nanoprecipitation preformed
polymer [60]. The components of the organic and
aqueous phases were weighed, placed in individual
beakers and subjected to sonication until complete
dissolution (15 min). Then, the organic phase (500 μL)
was poured into the aqueous phase (50 mL) and vortexed
for 1 min. The suspensions of polymeric nanoparticles
containing red propolis extract (NRPE) were submitted to
the characterization assays.
The NRPE were centrifuged for 15 min under a rotation
speed of 5000 rpm in a small centrifuge for Eppendorf
tubes (MiniSpin model) to form a solid pellet of non-rigidract (NRPE) using a nanocarrier in matrices system PCL-pluronic
NRPE A3 NRPE A4 NRPE A5 Placebo
27.0 57.0 60.0 54.0
60.0 14.4 10.0 -
13.0 28.6 30.0 46.0
do Nascimento et al. Nanoscale Research Letters  (2016) 11:301 Page 4 of 16consistency in the bottom of the Eppendorf tube, which
was later transferred to a 10-mL vial. The supernatant,
containing acetone and water, was discarded, and nano-
particles were diluted with milli-Q water (1:5, v/v) and
subjected to freeze-drying using three methods of drying.
The suspension of nanoparticles were dried at room
temperature (method A), by slow freeze method in freeze
at −20 °C (method B) and by fast freeze method
using liquid nitrogen (method C) to form the solid
nanoparticles. The same procedure was performed for
placebo composition (nanoparticles without red prop-
olis extract, NRPE placebo).
Freeze-Drying of Nanoparticles Loaded with Red Propolis
Extract
The suspensions of red propolis nanoparticles were
submitted to two freezing-drying processes: (1) slow
freezing, in which the suspensions of red propolis
nanoparticles were placed in a freezer at −20 °C for a
period between 48 and 120 h and immediately trans-
ferred to freeze-dryer to perform the drying process
for a period between 24 and 72 h (method B); and
(2) fast freezing with liquid nitrogen at −196 °C for a
period between 10 and 20 min and immediately
transferred to a freeze-dryer to perform the drying
process for a period between 24 and 36 h (method C).
Cryprotectant agents such as colloidal silicon dioxide
from 0.1 to 10 %, sucrose between 1 and 15 %, glucose
between 1 and 15 %, a solution containing combination
of colloidal silicon dioxide and sodium starch glycolate
(1:1, w/w) in concentration ranges between 10 and 30 %
and sodium starch glycolate solution from 0.10 to 30 %
were used.
The freeze-dryer used to dry the red propolis nanopar-
ticles was a Terroni equipment®, LD 1500 model (São
Paulo, Brazil), which comprises three shelves in a drying
chamber, a condenser to −43 ± 5 °C and a vacuum
pump. The equipment used for freeze-drying showed
temperature stability and low pressure in the condenser.
The system pressure remained below 300 μHg when the
suspensions of nanoparticles are presented in solid state.
The EEP and nanoparticles loaded with red propolis ex-
tract were subjected to physicochemical characterization,
investigation of antioxidant activity and leishmanicidal
assay using Leishmania (V.) braziliensis species.
Characterization of Suspension of Nanoparticles Loaded
with Red Propolis Extract
Particle size, Zeta Potencial and pH
The determination of average diameter and polydis-
persion index of nanoparticles in suspension were
made using dynamic light scattering. The suspensions
were fourfold diluted in Milli-Q water and analysed
in Zetasizer apparatus, model Nano-ZS from Malvern.The results were determined by the average of two
cycles of 20 scans. The zeta potential of the nanopar-
ticles suspension were obtained by the eletrophoretic
mobility technique in the zetasizer apparatus in which
the samples were diluted fourfold with Milli-Q water
and results were expressed in millivolts (mV) from
the average of two cycles of 20 scans. The nanoparticles
pH determinations were performed using a previously
calibrated glass electrode, and the measurements were
carried out directly from nanoparticles suspension
without any dilution.
Solid State Characterization of Red Propolis Extract
Loaded in Nanoparticles
Thermal Analysis
The calorimetric curves of polymeric nanoparticles
containing red propolis extract were obtained in a dif-
ferential scanning calorimeter, model DSC 50 from
Shimadzu (Tokyo, Japan), using a mass of (5.0 ± 10 % mg),
which were packed in aluminium capsules hermetically
sealed. The heating rate was 10 °C min−1 in the
temperature range 30–400 °C under an atmosphere of
nitrogen and flow rate of 50 mL min−1. The DSC was cali-
brated using indium and zinc standards according to the
Shimadzu suggested procedures.
ATR-FTIR
The nanopolymeric system loaded with propolis extract
in solid state was subjected to attenuated total reflect-
ance (ATR)-FTIR analysis, which was performed by ATR
in the wavenumber range 4000 to 400 cm−1 and 64
scans. The results were expressed in infrared transmit-
tance percentage. The equipment used was a Thermo
Scientific coupled to the Ommic software for data acqui-
sition. EEP and NRPE including placebo were analysed.
SEM Analysis
Scanning electron microscopy images were analysed to
confirm the morphology and approximate size of nano-
particles in solid state. The compositions of red propolis
nanoparticles were fixed on stubs with double carbon
tape and covered by a gold film during the metallization
process with 10 mA for 7 min in a System Sanyu Elec-
tron, Quick Coater Model SC-701. SEM micrographics
have been taken from Shimadzu microscope (SSX-550
Superscan model).
Determination of markers in Polymeric Nanoparticles
Using UPLC-DAD
The identification and quantification of flavonoids in
EEP and NRPE (in solid state) were performed using a
ultra performance liquid chromatography coupled with
diode array detector (UPLC-DAD) from Shimadzu con-
sisting of the following modules: a high-pressure pump
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Autoinjector (model SIL-20AXR), oven chromatographic
column, photodiode array detectors (model EPDM-20A)
and fluorescence detector (RF-20A model), a controller
(model CBM-20A) and a Shimadzu Labsolution soft-
ware. The separation of flavonoids occurred using a
reversed-phase column (C18, 150 × 4.6 mm; 5 μm), a
mobile phase that consisted of solvent A (Milli-Q water)
and solvent B (acetonitrile), pumped at a flow rate of
0.3 mL/min. The initial elution gradient consisted of
water (70 %) and acetonitrile (30 %) with a variation of
the percentage of acetonitrile to 100 % in 40 min
followed by an isocratic condition with acetonitrile
(100 %) up to 53 min and return to the initial condition
at 54 min, followed by isocratic conditions acetonitrile
(30 %) up to 60 min. This long method was developed in
order to wash the column during the analysis with
100 % of acetonitrile and avoid lack of accuracy and pre-
cision during the efficiency of entrapment assay and to
avoid column fouling and excessive pressure buildup by
irreversible retention of non-polar compounds (terpenes
and guttiferones present in red propolis extract).
Analytical standards were exactly weighed (2.0 mg)
transferred to 10-mL volumetric flasks to obtain a concen-
tration of 200 μg/mL. The working solutions were diluted
to obtain the final calibration curve concentrations of
7.50, 5.00, 2.50, 1.00, 0.50 and 0.15 μg/mL. These calibra-
tion curves were used for determining the content (assay)
of flavonoids in the extract (EEP) and NRPE loaded with
red propolis extract. The identification of flavonoids was
performed by retention time comparison with analytical
standards using the same analytical conditions on the
same working day.
Efficiency of Encapsulation (%)
The efficiency of encapsulation was also performed
using these same analytical conditions and with five
markers (liquiritigenin, pinobanksin, formononetin, isoli-
quiritigenin, biochanin A) present in the EPP, which
were determined in NRPE following the same separation
conditions. The propolis extract (100 mg) as a solid
(<1 % solvent) was solubilized in absolute ethanol with
ultrasonic bath (5 min) and transferred to a volumetric
flask (10 mL) to obtain a concentration of 10 mg/mL. A
further dilution step was performed to obtain working so-
lution of 1 mg/mL, and then final dilutions at 250 μg/mL
were performed. These solutions were filtered through fil-
ter units 0.22 μm, and (2 μL) were injected in the UPLC-
DAD system.
The efficiency of encapsulation (%) of flavonoids
loaded in NRPE was performed by solubilizing the solid
nanoparticles in a system of solvents consisting of acet-
one/ethanol (6:4, v/v) and also in the system of solvent
water/ethanol (7:3, v/v) to verify flavonoid concentrationoutside non-encapsulated nanospheres (%). Nanoparti-
cles loaded with red propolis extract (including NRPE
placebo) were weighed and solubilized to obtain a con-
centration of 1.0 mg/mL. They were then diluted to a
concentration corresponding to 250 μg/mL. The red
propolis extract was also analysed in the same concen-
trations, and the efficiency of encapsulation (%) of each
flavonoid in red propolis extract was determined using
the following equation:
Efficiency of encapsulation %ð Þ
¼ Concentration of flavonoid in NREP
Concentration of flavonoid in EEP
 
 100
Antioxidant Activity of the Polymeric Nanoparticles Using
DPPH Method
Quantitative assessment of the antioxidant activity of
EEP and NRPE were performed according to the
methods described in the literature [61] with few modifi-
cations. The inhibition of free radical DPPH by the sam-
ples was monitored by measuring the decrease in
absorbance of solutions with different concentrations.
The solvent ethanol was used as blank. A solution of
DPPH (3 mM) was prepared transferring 0.0118 g of
DPPH reagent to a 100-mL volumetric flask with
ethanol.
The EEP and NRPEs were prepared at an initial con-
centration of 1.0 mg/mL in the solvent system acetone/
ethanol (6:4, v/v). An aliquot of 400 μL was transferred
to a volumetric flask of 5 mL, and then 2.0 mL of DPPH
solution (3 mM) was added and diluted with ethanol
until achieving final concentrations of 80.0 μg/mL. The
reaction was left to develop in the dark at room
temperature (25 °C) over 30 min. The absorbance read-
ings were then performed with a spectrophotometer
(Model UV-1240, Shimadzu, Kyoto, Japan) at 518 nm.
In vitro Biological Assays
Antileishmanial Activity
L. (V.) braziliensis culture The strains of L. (V.) brazi-
liensis (IOC-L0566 - MHOM/BR/1975/M2903) from
FioCruz (Recife, Brazil) [62, 41] promastigotes were
cultured in vitro in biphasic medium Schneider’s/
Novy-McNeal-Nicolle, supplemented with 10 % of FBS,
50 U of penicillin/mL and 50 μg of streptomycin/mL, in-
cubated in a BOD camera at temperature of 26 °C.
Antileishmanial In vitro Assay Sample preparation:
previously, EEP and NRPE were exactly weighed and sol-
ubilized with DMSO/H2O (Milli-Q water) (75:25,v/v) to
obtain a stock solution of 10,000 μg/mL. Using this solv-
ent system, EEP was completely solubilized but NRPE
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were obtained transferring aliquots of EEP or NRPE
stock solution and diluting with Schneider’s medium
supplemented with 10 % BFS to obtain volumes of 1 mL
to each concentration at the range between 1000 and
5 μg/mL. In this way, the concentration of DMSO solv-
ent did not exceed 0.5 %, and at this concentration,
DMSO had no deleterious effect to the parasites [63].
Antileishmanial activity was carried out according
to Rocha et al. [64]. Aliquots of (100 μL) of the cul-
tured procyclic promastigotes cells of the parasite (at
a concentration of 4 × 106 cells/mL) immersed in the
Schneider’s medium with 10 % BFS in 96-well micro-
plates were incubated for a 24-h period in BOD cam-
era at 26 °C with 100 μL of samples (EEP and NRPE)
at the concentrations of 1000, 500, 400, 350, 300,
250, 200, 160, 100, 80, 60, 50, 40, 30, 20, 10 and
5 μg/mL. Afterwards, the morphology and parasites viabil-
ity were evaluated in an inverted microscope (Olympus -
IX70) to all concentrations tested, and then the parasite
number was determined through optical microscope in
the ×40 objective using a Neubauer chamber to express
the antileishmanial effect. The results were expressed as
the mean parasite growth inhibitory concentration (IC50).
Statistical Analyses
All results are presented as mean ± standard deviation for,
particle size, size distribution, zeta potential of NRPE, (%)
efficiency of entrapment (n = 3) using UPLC-DAD and
antioxidant activity by DPPH method. The mean ± stand-
ard deviation of the mean (SDM) relative to the percentage
(normalized graphs) of cell growth inhibition and parasite
growth inhibition were used to estimate the IC50 using
non-linear regression with the software GraphPad Prism,
version 5.0. The significance level was set as p < 0.05.
Results and Discussion
Characterization of Suspension of Nanoparticles Loaded
with Red Propolis Extract
Particle Size, pH and Zeta Potential
The results for the assays performed for suspensions of
nanoparticles (pH, particle size, polydispersity index andTable 2 Particle size and polydispersion index and zeta potential an
suspension
Composition Particle size (nm) Polydispersio
NRPE placebo 279.6 ± 1.4 0.169
NRPE A1 280.2 ± 8.7 0.089
NRPE A2 262.2 ± 6.60 0.128
NRPE A3 208.5 ± 4.79 0.115
NRPE A4 225.2 ± 7.72 0.096
NRPE A5 246.7 ± 9.2 0.113
Mean values refer to the mean of three determinations ± standard deviationzeta potential) of NRPE are shown in Table 2 and con-
firmed the characteristics of a nanoparticulate system.
The suspensions of NRPE presented with a homoge-
neous appearance macroscopically, opaque with Tyndall
effect and light pink to intense pink coloured, depending
on the concentration of the propolis extract loaded in
nanoparticles. The opaque appearance and presence of
the Tyndall effect in suspensions of nanoparticles can
be indicative of the formation of nanospheres by
nanoprecipitation method and can be explained by
the Gibbs-Marangoni effect [65].
Values of particle size in the nanometric scale varying
between 208.5 and 280.2 nm with polydispersity index
from 0.089 to 0.169 demonstrating unimodal model, i.e.,
monodisperse particles. The pH of the suspensions of
nanoparticles (NRPE) was similar to the placebo with
slightly acidic values between 5.83 and 6.15.The slightly
acidic characteristic of suspension of nanoparticles can
be attributed to the presence of the PCL polymer and
the greater number of carboxyl end groups [66], and pH
values between 4.6 and 6.0 were due to PCL polymer
[67]. The pH is an important parameter to evaluate the
stability of the nanoparticles in suspension and can be
an indicator of polymer degradation or drug diffusion to
aqueous medium.
The zeta potential varied from −18.6 to −26.8 mV,
except NRPE A3 (−12.7 mV). Changes in the size of
nanoparticles may be influenced by the nature and
concentration of the polymer in the organic phase,
polarity of solvent, the nature and concentration of
the surfactants in the aqueous phase [68]. Chawla and
Amiji [32] observed changes in particle size after re-
moval of the pluronic F-68 surfactant with a signifi-
cant increase in particle size. Therefore, the presence
of pluronic in the nanoprecipitation process acts as a
dispersant and also as a stabilizer. Solid materials
have electric charge on its surface, after contact with
a liquid. The high values of the zeta potential, either
negative or positive (±30 mV), represent the achieve-
ment of a stable suspension, by repulsion between
particles which prevents the occurrence of aggregation of
the nanoparticles. The suspensions of nanoparticles wered pH of nanoparticles loaded with red propolis extract in
n index (PDI) Zeta potential (mV) pH
−33.5 ± 6.06 6.0 ± 0.1
−26.8 ± 4.64 6.1 ± 0.1
−18.6 ± 3.66 6.1 ± 0.2
−12.7 ± 5.24 5.8 ± 0.2
−24.2 ± 5.24 6.0 ± 0.1
−19.1 ± 4.61 6.1 ± 0.1
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was observed. In our studies, we monitored the stability of
the suspensions of nanoparticles during 30 days and no
aggregations or precipitation was observed, except for
NRPE A3. Only NRPE A3 has developed precipitation
after 10 days of storage.
Our strategies were prepare suspensions of nanoparti-
cles or solid lipid nanoparticles loaded with red propolis
extract and then incorporate it in cosmestic composi-
tions (semisolid composition like cosmestic creams).
Thus, these zeta potential values were sufficient to
stabilize the nanoparticles of red propolis extract. Nega-
tive values for zeta potential are a desired condition to
promote the permeation of molecules across the skin
barriers especially for transdermal compositions. Nair
et al. [69] reported that slightly negative or positive
charges on the surface of the particles can control pa-
rameters such as the solubility and stability, as well as
prevent loss of nanoparticles in undesired locations. In
this way, it is a sine qua non condition for this natural
product to maintain the multi-target purpose in bio-
logical systems. This stability of the suspensions of
nanoparticles for our strategy (semisolid composition
like cosmetic creams) is sufficient to stabilize the nano-
particles of red propolis extract.
Characterization of Red Propolis Nanoparticles in Solid
State
Thermal Analysis
The accompanying Fig. 1 shows DSC thermograms of the
propolis extract, the polymeric coating matrix (PCL-
pluronic) and NRPE compositions. The DSC thermogram
of the red propolis extract showed four endotherm events
at temperatures of 81.7, 92.0, 107.0 and 135.0 °C. Three
endothermic peaks between 81.7 and 107.0 °C correspond
to water volatilization, and the fourth endothermic peakFig. 1 DSC curves of EEP and nanoparticles loaded with EEP in different coat 135 °C refer to fusion processes of low molecular
weight compounds like flavonoids in mixture and other
phenolic compounds present in the propolis extract.
The polymers PCL and pluronic were submitted to DSC
analysis and presented endothermic peak of fusion at 58
and 60 °C, respectively, while polymeric coating matrix
showed an endothermic event at the melting temperature
60.5 °C and behaved similar NRPE to the NRPE composi-
tions in the temperature range of 48 and 59 °C with no
additional endothermic event at temperature ranges re-
lated to propolis extract (81.7, 92.0, 107 and 135 °C), sug-
gesting an encapsulation phenomena of red propolis
extract by the polymeric coating matrices.ATR-FTIR
Figure 2 presents ATR-FTIR spectra of propolis extract,
polymeric coating matrix and NRPE compositions. ATR-
FTIR spectrum of the propolis extract showed typical
hydrogen-bonded O–H stretch of phenolic compounds
3336 cm−1 (phenolic hydroxyl group), absorptions at 1617,
1496 and 1450 cm−1 corresponding to the C=C stretches
of aromatic ring and the bands at 1045 cm−1 attributed to
the stretch of aromatic ether C–O bond (for flavonoids) as
well as the band at 877 cm−1 corresponding to the angular
deformation outside the plane of aromatic C–H. The
ATR-FTIR spectra of the polymeric coating matrices
and NRPE compositions showed similar stretches at
2863 cm−1 and 1400–1340 cm−1 and are related to axial
and angular stretches, respectively, for C–H of CH2. In
addition, axial stretches of carbonyl aliphatic ketone
(C=O) at 1725 cm−1 and axial and angular deformation
C–(CO)–C at 1171 cm−1 were observed. Disappearance
of the axial stretching of C=C (characteristic of aromatic
ring) in flavonoids and phenolic compounds are present







Fig. 2 ATR-FTIR spectra of EEP and nanoparticles loaded with EEP in different compositions. Comparative ATR-FTIR spectra of NRPE Placebo and
Ethanolic Extract of Propolis (a), NRPE Placebo and NRPE A1 (b), NRPE Placebo and NRPE A2 (c), NRPE Placebo and NRPE A3 (d), NRPE Placebo
and NRPE A4 (e) and NRPE Placebo and NRPE A5 (f)
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extract during the processes of nanoprecipitation and
drying using freeze-drying for NRPE.
SEM Analysis
Figure 3 shows the scanning electron microscopy of
NRPE A1, A2 and A4 using drying methods A and B.
Photomicrographs with magnification of ×2000 (range
5 μm) and magnification up to ×10,000 (scale 1 μm)
show submicron particles.
Figure 3a, b (NRPE A1 and NRPE A1) was obtained
by the method of drying at room temperature (natural
drying). Figure 3a, b shows photomicrographs of submi-
cron particles (between 450 and 960 nm) obtained by
drying process at room temperature (method A) with
the formation of nanocrystals, and Fig. 3c, d showsscanning electron microscopy of NRPE A2 like submi-
cron particles (between 400 and 960 nm) with the for-
mation of amorphous aggregates when obtained using
drying method B (slow freezing at freezer −20 °C).
Figure 3 shows scanning electron microscopy of NRPE
A4 obtained by method C of drying. Micrographs with
magnification of ×7000 (scale 2 μm) and magnification up
to ×10,000 (scale 1 μm) showing the polymeric nanoparti-
cles loaded with red propolis extract. Figure 3e, f (NRPE
A4) was obtained by drying method C. Figure 3e shows a
micrograph of the nanoparticles (200 and 350 nm) using
colloidal silicon dioxide as cryoprotectant, and Fig. 3f
shows a photomicrograph of the nanoparticles (between
175 and 320 nm) using a sodium starch glycolate as cryo-
protectant. Method C presented spherical nanoparticles in




Fig. 3 Scanning electron microscopy of NRPE in different freeze-drying conditions. a, b Method A of drying at room temperature in freeze-drying
(NRPE A2). c, d Method B of drying in freeze-drying (NRPE A21). e, f Method C of drying in freeze-drying using cryoprotectants: colloidal silicon
dioxide e and sodium starch glycolate f of the NRPE A4 composition
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Using UPLC-DAD
The chromatograms by UPLC-DAD in Fig. 4 show the
polymeric coating matrices (placebo) (Fig. 4a), red prop-
olis extract (Fig. 4b), NRPE A1 composition (Fig. 4c) and
NRPE A2 composition (Fig. 4d). Identification of fla-
vonoids and isoflavonoids present in the red propolis
extract and NRPE compositions are shown. Chroma-
tographic peaks for flavonoids in the polymeric coat-
ing matrice (placebo) were not observed (Fig. 4a).
Figure 4b–d shows the presence of flavonoids (1)
liquiritigenin (12.53 min), (2) pinobanksin (15.68 min), (3)
isoliquiritigenin (17.26 min) (4) formononetin (18.13 min)
(5) pinocembrin (23.12 min) and (6) biochanin A
(23.81 min) at the corresponding retention times similar
to those used as analytical standards during the develop-
ment of chromatographic method. The method showed
linearity, precision and accuracy in the concentration
range between 0.15 and 5.0 μg/mL and was previ-
ously validated for six flavonoids identified as markers
in red propolis extract and NRPE. It was possible to
determine the concentration of five markers presentin EEP and the nanoparticles loaded with propolis extract
with intermediary precision of 1.61, 2.65, 3.00, 5.05 and
4.65 % for liquiritigenin, pinobanksin, isoliquiritigenin, for-
mononetin and biochanin A, respectively (Additional file
1: Table S1). Accuracy of 8.28, 10.51, −7.43, −2.48 and
13.00 % was observed in the low limit of quantification
(0.15 μg/mL), respectively, for the flavonoids cited in this
order (Additional file 2: Table S2). Pinocembrin presented
low levels in nanoparticles, and it was not used for deter-
mination of efficiency of entrapment assay. Table 3 shows
the concentrations (μg/mL) obtained for each biomarker,
and the data was used to determine the efficiency of en-
trapment and to establish the range of concentration of
red propolis extract in biological assays. Variability on the
results up to 13 % can be considered as a method vari-
ation and can be explained due to use of gradient method
used for eluted flavonoids with different grade of polarity
and the complexity of the sample (a pool of flavonoids).
Efficiency of Encapsulation (%)
Five marker compounds representing the major flavo-
noids found in the samples were used for determination
a b
c d











Fig. 4 Determination of markers of red propolis extract in EEP and NRPE using UPLC-DAD. Chromatogram of the placebo (a), EEP (b), NRPE A1 (c)
and NRPE A2 (d). Identification of flavonoids (1) liquiritigenin (2) pinobanksin, (3) isoliquiritigenin, (4) formononetin, (5) biochanin A and
(6) pinocembrin at the wavelength of 280 nm
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served that liquiritigenin showed greater losses during
the drying process of NRPE. The compositions NRPE
A1, A4 and A5 showed higher content values and (%)
efficiency of encapsulation, while NRPE A2 and A3
showed the greatest loss for liquiritigenin (Table 4).
Greater percentage of encapsulation for the flavonoids
isoliquiritigenin, formononetin and biochanin A was ob-
served and was superior to 75 %, except in compositions
NRPE A2 (Table 4). The percentage of non-encapsulatedTable 3 Determination of the markers present in EEP and nanoparti
Concentration of flavonoids(μg/mL) ± SDa
Composition A B
EEP 2.290 ± 0.760 0.330 ± 0.003
NRPE A1 1.240 ± 0.040 0.329 ± 0.004
NRPE A2 0.950 ± 0.010 0.238 ± 0.020
NRPE A3 0.820 ± 0.01 0.200 ± 0.004
NRPE A4 1.216 ± 0.004 0.240 ± 0.003
NRPE A5 1.168 ± 0.003 0.230 ± 0.001
A liquiritigenin, B pinobanksin, C isoliquiritigenin, D formononetin, E biochanin A
aMean values refer to the mean of three determinations ± standard deviationflavonoids was evaluated, and a high concentration of
flavonoids on the surface of the nanoparticles for com-
positions NRPE A3 (41.48 %) and NRPE A2 (39.47 %)
was observed (Table 5). Approximately the percentage of
40 % of flavonoids loaded in the nanoparticle can be
retained on the outer walls of the nanoparticles, and this
point is very important to maintain the biological activ-
ity of this apiceutical extract. This phenomenon oc-
curred in all compositions but in the concentration of
propolis extract was greater than 30 % (NRPE A2 andcles loaded with red propolis extract using UPLC-DAD
C D E
2.510 ± 0.010 2.960 ± 0.010 0.371 ± 0.010
2.400 ± 0.040 1.740 ± 0.010 0.370 ± 0.004
1.770 ± 0.020 1.740 ± 0.010 0.324 ± 0.003
2.032 ± 0.001 1.860 ± 0.010 0.318 ± 0.001
1.888 ± 0.001 2.032 ± 0.022 0.327 ± 0.002
1.792 ± 0.031 2.002 ± 0.013 0.321 ± 0.002
Table 4 Efficiency of encapsulation (%) of flavonoid marker compounds present in the nanoparticles loaded with red propolis extract
(%) Efficiency of encapsulation of flavonoids using UPLC-DADa
Composition A B C D E
NRPE A1 53.0 ± 1.6 99.8 ± 1.7 95.6 ± 1.7 77.4 ± 1.7 99.8 ± 1.7
NRPE A2 41.3 ± 0.4 72.0 ± 0.9 70.5 ± 0.9 58.6 ± 0.5 82.1 ± 1.3
NRPE A3 38.0 ± 0.8 60.9 ± 1.3 103.6 ± 0.7 75.4 ± 0.6 85.7 ± 0.2
NRPE A4 57.3 ± 0.3 72.9 ± 0.8 96.6 ± 0.1 82.2 ± 1.4 88.3 ± 1.7
NRPE A5 54.9 ± 0.2 70.9 ± 0.2 91.5 ± 2.5 81.2 ± 0.8 86.4 ± 1.7
A liquiritigenin, B pinobanksin, C isoliquiritigenin, D formononetin, E biochanin A
aMean values and standard deviation determinate in triplicate
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extract, respectively) also due to minor proportion of the
polymeric system (PCL-pluronic) required for encapsu-
lating the flavonoids present in red propolis extract. A
percentage of 70 % of the polymeric system (PCL-pluro-
nic) and 30 % of red propolis extract was considered
optimum to encapsulate flavonoids from red propolis
and can be considered a limit to encapsulate the flavo-
noids of red propolis extract. A higher concentration of
red propolis extract on the polymeric system provoked
saturation of the system and reduced the efficiency of
encapsulation. The NRPE A1, A4 and A5 demonstrated
greater capacity of entrapment to the flavonoids of prop-
olis extract compared with other compositions. The
NRPE A2 and NRPE A3 displayed evidence of flavonoids
adsorbed on the external surface of nanoparticles
(Table 5).
The compositions NRPE A1 and NRPE A2 showed a
polymeric system PCL-pluronic that do not compromise
the stability, the potency, or biological activity of
flavonoids in propolis extract which are present inside
or on the outer walls of the nanoparticles. No strong
chemical interaction was shown; only physical interac-
tions between embedded extract to the polymeric system
were observed. The results of antioxidant activity and
leishmanicidal activity demonstrate this statementTable 5 Efficiency of encapsulation (%) and non-encapsulation prop
nanoparticles of red propolis extract







Mean values and standard deviation determinate in triplicate
E.E. efficiency of encapsulation, N.E. non-encapsulated
aExternal determination of formononetin
bExternal determination of liquiritigenin + pinobanksin + isoliquiritigenin + formono
cExternal determination of liquiritigenin and formononetin
dExternal determination of liquiritigenin + isoliquiritigenin + formononetin(Table 5 and Fig. 5). The high content of PCL-pluronic
system in relation to propolis extract affected the potency
of the compositions NRPE A4 at the leishmanial assay
(Table 5 and Fig. 5). The composition NRPE A3 demon-
strated vulnerability to oxidative degradation by air or
light during the drying process by freeze drying, evidenced
by the darkening of the material thus obtained.
Generally, an apiceutical extract is a “multiple-compo-
nent agent” and presents different chemical classes of
compounds like phenolic acids, esters, flavonoids and
terpenes, and each chemical class display a particular
chemical reactivity and is likely to react with light, air,
water and other extrinsic factors promoting rapid
degradation or inactivation of biological activity. The
polymeric encapsulation of red propolis extract was a
successful strategy to protect this apiceutical extract
against degradation and inactivating itself; besides, this
encapsulation process was able to store the red propolis
extract during 9 months in solid-state form.
Antioxidant Activity of the Polymeric Nanoparticles Using
DPPH Method
The NRPE displayed good antioxidant activity with in-
hibition values between 76.22 and 81.40 % for composi-
tions and only 12.28 to 13.75 % for placebo sample
(Table 6). The development of polymeric nanoparticlesortion (%) of the flavonoid marker compounds present in
onoids using UPLC-DAD







Fig. 5 Determination of IC50 for leishmanicidal assay against Leishmania
(V.) braziliensis using normalized graph
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problem in the field of cosmetic science and phytocos-
metics since the presence of phenolics in high concen-
tration in these preparations can result in chemical
incompatibilities, fast darkening of these semisolid
preparations by the autoxidation phenomena between
phenolic compounds and lipids from cosmetic excipi-
ents. Therefore, the nanoencapsulation of the apiceuti-
cal extract into inert polymeric systems such as
polycaprolactone and pluronic is necessary to coat the
flavonoids and protect them from possible autooxidative
reactions favoured by the other cosmetic constituents.
These results demonstrate that the compositions NRPE
will act as agents that inhibit oxidative processes and
act as antioxidants in biological systems. Antioxidant
activity in vitro using DPPH assay may be the first indi-
cator of action of these polymeric nanoparticles on the
skin and associated structures functioning as skin anti-
ageing agent, and inhibiting muco-cutaneous growth of
parasites.Table 6 Antioxidant activity (%AOA) of EEP and its
nanoparticles loaded with red propolis extract
(% AOA)
Composition (%)E.E.a (%)N.E.a ∑(%E.E. + %N.E.)
Trolox 99.50 a 99.50
EEP 98.00 a 98.00
NRPE A1 81.40 ± 2.75 30.73 ± 1.04 112.13
NRPE A2 76.63 ± 6.86 27.18 ± 0.95 103.81
NRPE A3 79.51 ± 2.13 36.75 ± 1.33 116.26
NRPE A4 77.35 ± 2.98 38.10 ± 0.36 115.45
NRPE A5 76.22 ± 5.74 18.27 ± 1.77 94.49
Free radical DPPH sequestering activity (%) of the ethanolic extract of Brazilian
red propolis and its nanoparticles loaded with red propolis extract
aMean values refer to the mean of three determinations ± standard deviationIn vitro Biological Assays
Antileishmanial Activity
The EEP and NRPE presented antileishmanial activity
proven by IC50 values. The EEP showed an IC50 of
37.9 μg/mL (CI 95 % 33.57–43.11 μg/mL), and NRPE
samples showed an IC50 of 31.34 μg/mL (CI 95 %
27.24–35.71 μg/mL) (NRPE A1), 47.23 μg/mL (CI 95 %
42.41–53.23 μg/mL) (NRPE A2), 154.2 μg/mL (CI 95 %
140.60–169.20 μg/mL) (NRPE A3) and 193.2 μg/mL (CI
95 % 187.60–201.40 μg/mL) (NRPE A4) (Fig. 5A). In
general, the compositions of EEP-loaded into nanoparti-
cles comprising 30 and 40 % of EEP maintained antil-
eishmanial activity similar to the EEP in its original
form. Leishmanicidal activity of the prepared nanoparti-
cles has not been found to be a concentration-
dependent response but is related to efficiency of encap-
sulation and ratio between polymeric matrix and extract
of red propolis present in the nanoparticles. The NRPE
A4 composition demonstrated the lowest amount of
EEP and had the lowest leishmanicidal activity of these
compositions. In general, the polymeric matrix (PCL-
pluronic) has shown to be a controlled release system
very efficient for release of drugs, and in this particular
composition (NREP A4), the polymeric system served as
a delayed release system by reducing the release of flavo-
noids present in the propolis extract against L. brazilien-
sis. The NRPE A3 composition presented highest loss
for markers liquiritigenin and formononetin, and the
highest amount of markers determined outside of nano-
particles was observed (Tables 4 and 5).
Propolis extracts from different part of the world
have been investigated against leishmania parasites
and has demonstrated relevant leishmanicidal activity.
Duran et al. [70] showed antileishmanial activity for
two types of Turkey propolis extracts (propolis Hatay
and Bursa propolis) and demonstrated an IC50 of 250
and 500 μg/mL. Another relevant study by Duran
et al. [71] revealed good results for Adana propolis
against leishmania parasite in concentrations above
250 μg/mL. Another type of Turkish propolis extract
(Kayseri propolis) studied by Ozbilge et al. [72]
showed excellent leishmanicidal activity against Leishmania
tropica with an IC50 of 32 μg/mL.
Comparative study of the green propolis extracts from
Brazilian and Bulgarian propolis extract carried out by
Machado et al. [73] showed leishmanicidal activity
against four different species of Leishmania (amazonen-
sis, braziliensis, chagasi and major). Brazilian green
propolis extract showed IC50 close to 49 μg/mL against
L. braziliensis, L. chagasi and L. major species, while the
Bulgarian propolis extract showed leishmanicidal activity
for L. amazonensis, L. chagasi and L. major species with
IC50 between 2.8 and 41.3 μg/mL. Excellent leishmanici-
dal activity of Bulgarian propolis can be explained by the
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pinobanksin esters, pinocembrine, chrysin, some phen-
olic acids and phenolic acid esters [73]. Brief description
of the scientific literature shows that some flavonoid
aglycones such as quercetin, luteolin and fisetin have
high leishmanicidal activity with IC50 values in the
range from 0.6 to 0.8μg/mL. Flavonoid glycosides
such as rutin, quercitrin and isoquercitrin have also
demonstrated leishmanicidal activity. Scientific research
by Da Silva et al. [74] showed that the Brazilian green
propolis displays leishmanicidal activity in concentrations
ranging from 5 to 100 μg/mL in in vitro cytotoxicity
studies at the times 24, 96 and 168 h. Miranda et al. [75]
demonstrated efficacy of combined therapy of complex
Ru-NO (NO donor) and Brazilian green propolis extract
in the treatment of American cutaneous leishmaniasis
(ATL).
Brazilian red propolis extract with high concentra-
tions of prenylated benzophenones has been evaluated
in macrophages infected with L. amazonensis and dem-
onstrated that a concentration of 25 μg/mL is capable
of increasing the reductive activity of MTT being active
against these intracellular parasites present in macro-
phages [76]. In our studies, the hydroalcoholic propolis
extract showed antileishmanial activity against L. brazi-
liensis with IC50 values ≅38.0 μg/mL, and the same
results were obtained with polymeric nanoparticles
loaded with propolis extract with IC50 values between
31.3 and 47.2 μg/mL for NRPE A1 and NRPE A2,
respectively.
We have developed a method to evaluate only
biological activity of nanoparticles (NRPE) against the
parasite L. (V.) braziliensis that is a biological quality
control method for these nanoparticles, and it is con-
sidered as an intermediary product (bulk form) during
the production of semisolids (cosmetic creams). In
our experiments, we proved similar efficacy of NRPE
(nanoparticle loaded with red propolis) to EEP (etha-
nolic extract of red propolis) for NRPE A1 and NRPE
A2, and these nanoparticles will deserve further
development efforts aimed at a final composition
(cosmetic cream) against cutaneous leishmaniasis.
Previous studies using emulsionated curcumin [77]
and phospholipid nanoparticles of ursolic acid [78]
obtained using preparation techniques such as emulsi-
fication-evaporation and amphiphilic self-assembly
was shown to affect parameters such as absorption,
half-life and bioavailability when compared to the ef-
fect of the isolated substances. Thus, in the final
formulation excipients could be taylored to modulate
and improve pharmacokinetic parameters of natural
products [69].
Our chormatographic study determined the presence
of some isoflavonoids (formononetin, biochanin A),dyhydroflavonol (pinobanksin), chalcone (isoliquiriti-
genin) and flavonone (liquiritigenin), but formononetin,
isoliquiritigenin and liquiritigenin were considered the
major flavonoids present in the EEP and also in NRPE.
It was previously shown that the presence of isoliquiriti-
genin, a chalcone, and other flavonoids and isoflavonoids
present in EEP and in the prepared nanoparticulate ex-
tract (NRPE) can inhibit the activity of L. (V.) braziliensis
through different biochemical targets such as cytoplas-
mic membrane and the mitochondrial respiratory com-
plex. The propolis extract present a multitude of
constituents that can act on multiple biochemical targets
affecting the balance of complex cellular networks in a
way that is currently not fully understood such as the
multi target efficacy model proposed by CSERMELY
et al. [2].
Recent studies showed that flavonoid chalcones have
high activity in inhibiting the growth of parasites includ-
ing Leishmania. Torres-Santos et al. [79] demonstrated
that naturally occurring chalcones (dihydromethoxylated
chalcone) alter the biosynthesis of sterols in L. amazo-
nensis and promote ergosterol accumulation and choles-
terol decrease. This alteration resulted into increase the
membrane fluidity and toxic effect to the parasite with
IC50 of 5.5 μM. Previous studies have shown a similar
mechanism of action for amphotericin B (leishmanicidal
drug) [80].
Studies of Chen et al. [81] showed that chalcones
(licochalcone A in specific study) can destroy the ultra-
structure of the parasite’s mitochondria and inhibit
mitochondrial respiration and activity of mitochondrial
dehydrogenase enzymes, especially the activity of the
parasite´s specific fumarate reductase (FDH). Some
studies have presented a similar mechanism of action for
the antileishmanial drug paromonycin, which binds to
the mitochondrial 30S ribosomal subunit as well as the
induction of respiratory dysfunction and depolarization
of the mitochondrial membrane [82, 83]. Figure 6 sum-
marizes these two hypothesized mechanisms of growth
inhibition of leishmania using a pool of flavonoids in
EEP or NRPE.
Conclusions
Nanoparticles (200-800nm) loaded with red propolis
extract were prepared and characterized both as suspen-
sions and in solid state form, based on PLC-pluronic
matrix system. This copolymeric matrix system was able
to encapsulate different flavonoids from red propolis
extract with particular characteristics of solubility and
antioxidant activity.
Nanoparticles loaded with red propolis extract in
multidrug co-delivery system and EEP presented cyto-
toxic activity on L. braziliensis. Red propolis extract
loaded in nanoparticles was shown to be a potential
Fig. 6 Some hypothesized biochemical mechanism of cellular debridement of Leishmania (V.) braziliensis species by the flavonoids of red propolis
extract (EEP) or NRPE loaded with red propolis extract
do Nascimento et al. Nanoscale Research Letters  (2016) 11:301 Page 14 of 16candidate as intermediate products for preparation of
various pharmaceutical dosage forms containing red
propolis extract in the therapy against neglected dis-
eases such as leishmaniasis.
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